clorgyline has been researched along with Obsessive-Compulsive Disorder in 4 studies
Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.
Obsessive-Compulsive Disorder: An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with obsessive-compulsive disorder who met DSM-III criteria and who had been ill for at least one year were studied in a double-blind, randomized, crossover comparison of the tricyclic antidepressant clomipramine hydrochloride and the monoamine oxidase inhibitor clorgyline hydrochloride." | 9.05 | Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline. ( Alterman, I; Cohen, RM; Insel, TR; Kilts, C; Linnoila, M; Murphy, DL, 1983) |
| "Patients with obsessive-compulsive disorder who met DSM-III criteria and who had been ill for at least one year were studied in a double-blind, randomized, crossover comparison of the tricyclic antidepressant clomipramine hydrochloride and the monoamine oxidase inhibitor clorgyline hydrochloride." | 5.05 | Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline. ( Alterman, I; Cohen, RM; Insel, TR; Kilts, C; Linnoila, M; Murphy, DL, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Insel, TR | 3 |
| Murphy, DL | 3 |
| Cohen, RM | 1 |
| Alterman, I | 1 |
| Kilts, C | 1 |
| Linnoila, M | 1 |
| Zahn, TP | 1 |
| de Montigny, C | 1 |
| Blier, P | 1 |
| Mueller, EA | 1 |
| Gillin, JC | 1 |
| Siever, LJ | 1 |
2 trials available for clorgyline and Obsessive-Compulsive Disorder
| Article | Year |
|---|---|
Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline.
Topics: Adult; Clinical Trials as Topic; Clomipramine; Clorgyline; Double-Blind Method; Female; Humans; Male | 1983 |
Psychophysiological changes during pharmacological treatment of patients with obsessive compulsive disorder.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Clomipramine; Clorgyline; Double-Blind Method; Fe | 1984 |
2 other studies available for clorgyline and Obsessive-Compulsive Disorder
| Article | Year |
|---|---|
Desensitization of terminal 5-HT autoreceptors by 5-HT reuptake blockers.
Topics: Animals; Citalopram; Clomipramine; Clorgyline; Humans; Monoamine Oxidase Inhibitors; Obsessive-Compu | 1991 |
Tricyclic response in obsessive compulsive disorder.
Topics: Adolescent; Adult; Clomipramine; Clorgyline; Desipramine; Dexamethasone; Double-Blind Method; Electr | 1985 |